Shelley B. Thunen

Insider Reports History

Location
Aliso Viejo, CA
Signature
/s/ Daniel R. Chevallard, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shelley B. Thunen:

Company Role Class Num Shares Value Price $ Report Date Ownership
RxSight, Inc. Co-President and Chief Financial Officer Common Stock 38,354 $166,403 $4.34 14 Apr 2025 Direct
AEON Biopharma, Inc. Director Restricted Stock Units 308,641 21 May 2025 Direct
AEON Biopharma, Inc. Director Stock Option 96,210 31 Aug 2024 Direct
AEON Biopharma, Inc. Director Class A Common Stock 36,021 31 Aug 2024 Direct
LENZ Therapeutics, Inc. Director Stock Option (right to buy) 13,500 11 Jun 2025 Direct
RxSight, Inc. Co-President and Chief Financial Officer Stock Option (right to buy) 0 14 Apr 2025 Direct

Insider Reports Filed by Shelley B. Thunen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LENZ LENZ Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director 11 Jun 2025, 17:46
AEON AEON Biopharma, Inc. 21 May 2025 1 $0 4 Director 23 May 2025, 17:04
RXST RxSight, Inc. 14 Apr 2025 3 +$33,806 4 Co-President and Chief Financial Officer 15 Apr 2025, 20:57
RXST RxSight, Inc. 27 Feb 2025 1 $0 4 Co-President and Chief Financial Officer 27 Feb 2025, 20:04
RXST RxSight, Inc. 01 Oct 2024 5 -$486,730 4 Co-President and Chief Financial Officer 02 Oct 2024, 16:11
AEON AEON Biopharma, Inc. 31 Aug 2024 2 $0 4 Director 04 Sep 2024, 21:51
RXST RxSight, Inc. 07 Aug 2024 1 $0 4 Co-President and Chief Financial Officer 08 Aug 2024, 16:12
RXST RxSight, Inc. 15 Jul 2024 3 +$71,632 4 Co-President and Chief Financial Officer 16 Jul 2024, 20:15
RXST RxSight, Inc. 01 Jul 2024 6 -$923,833 4 Chief Financial Officer 02 Jul 2024, 16:25
RXST RxSight, Inc. 01 May 2024 4 -$367,077 4 Chief Financial Officer 02 May 2024, 16:58
RXST RxSight, Inc. 01 Apr 2024 6 -$997,946 4 Chief Financial Officer 02 Apr 2024, 16:18
LENZ LENZ Therapeutics, Inc. 21 Mar 2024 1 $0 4 Director 25 Mar 2024, 20:44
LENZ LENZ Therapeutics, Inc. 21 Mar 2024 0 $0 3 Director 25 Mar 2024, 20:28
AEON AEON Biopharma, Inc. 19 Mar 2024 1 $0 4 Director 21 Mar 2024, 19:52
RXST RxSight, Inc. 04 Mar 2024 1 $0 4 Chief Financial Officer 06 Mar 2024, 16:25
RXST RxSight, Inc. 01 Mar 2024 5 -$407,743 4 Chief Financial Officer 05 Mar 2024, 16:05
RXST RxSight, Inc. 05 Feb 2024 8 -$778,964 4 Chief Financial Officer 07 Feb 2024, 17:18
RXST RxSight, Inc. 26 Jan 2024 5 -$998,054 4 Chief Financial Officer 29 Jan 2024, 17:36
RXST RxSight, Inc. 02 Jan 2024 4 -$236,426 4 Chief Financial Officer 03 Jan 2024, 16:11
RXST RxSight, Inc. 15 Dec 2023 5 -$1,261,310 4 Chief Financial Officer 18 Dec 2023, 19:09
AEON AEON Biopharma, Inc. 14 Aug 2023 1 $0 4 Director 16 Aug 2023, 16:07
AEON AEON Biopharma, Inc. 21 Jul 2023 0 $0 3 Director 24 Jul 2023, 21:04
RXST RxSight, Inc. 09 Mar 2023 1 $0 4 Chief Financial Officer 10 Mar 2023, 15:13
RXST RxSight, Inc. 31 Jul 2021 1 $0 4 Chief Financial Officer 02 Aug 2021, 20:28
RXST RxSight, Inc. 29 Jul 2021 0 $0 3 Chief Financial Officer 29 Jul 2021, 10:34